e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Different aspects of COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
X. Pomares, C. Monton, M. Gallego, D. Mariscal, E. Castaner, J. Valles, A. Marin (Sabadell, Spain)
Source:
Annual Congress 2007 - Different aspects of COPD exacerbations
Session:
Different aspects of COPD exacerbations
Session type:
Electronic Poster Discussion
Number:
1380
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Pomares, C. Monton, M. Gallego, D. Mariscal, E. Castaner, J. Valles, A. Marin (Sabadell, Spain). C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations. Eur Respir J 2007; 30: Suppl. 51, 1380
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD
Source: Eur Respir J 2015; 45: 76-86
Year: 2015
The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006
Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Procalcitonin use in acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
COPD, asthma and C-reactive protein
Source: Eur Respir J 2006; 27: 874-876
Year: 2006
Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Procalcitonin and C-reactive protein levels in infective attacks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept